Consensus Guidance May Improve Sinonasal Mass Outcomes - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Consensus Guidance May Improve Sinonasal Mass Outcomes

Multidisciplinary recommendations emphasize biopsy technique, imaging, and pathology review in patients with suspected sinonasal malignancy.

  • By

  • Andrea Surnit

  • June 2, 2026

  • 4 min

Share

Original Source(s)

Consensus Guidance May Improve Sinonasal Mass Outcomes

  • by Andrea Surnit

  • June 2, 2026

Related Content

Promising early results for a new treatment in head and neck cancer

Victoria Villaflor, MD shared promising early results at ASCO 2026 for a new treatment approach in head and neck cancer.

  • June 24, 2026

  • 1 min
FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Exploring the Effects of Frailty and Sarcopenia on Dysphagia in Head and Neck Cancer: A Scoping Review